Teresa C Williams, David J Jackson, Steven Maltby, Ross P Walton, Yee-Mann Ching, Nicholas Glanville, Aran Singanayagam, Jennifer J Brewins, Deborah Clarke, Aurica G Hirsman, Su-Ling Loo, Lan Wei, Janine E Beale, Paolo Casolari, Gaetano Caramori, Alberto Papi, Maria Belvisi, Peter A B Wark, Sebastian L Johnston, Michael R Edwards, Nathan W Bartlett
The interplay of type-2 inflammation and antiviral immunity underpins asthma exacerbation pathogenesis. Virus infection induces type-2 inflammation-promoting chemokines CCL17 and CCL22 in asthma; however, mechanisms regulating induction are poorly understood. By using a human rhinovirus (RV) challenge model in human airway epithelial cells in vitro and mice in vivo, we assessed mechanisms regulating CCL17 and CCL22 expression. Subjects with mild to moderate asthma and healthy volunteers were experimentally infected with RV and airway CCL17 and CCL22 protein quantified...
March 2021: American Journal of Respiratory Cell and Molecular Biology